pBZ-attBtxnl4b
(Plasmid
#18667)
-
Purposecloning vector containing attB flanked TXNL4B useful for recombination based conversion of conventional vectors to Gateway compatible destination vectors
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 18667 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBZ
- Backbone size w/o insert (bp) 2930
- Total vector size (bp) 3495
-
Modifications to backbonepBZ is a derivative of pBlueScript II SK with a modified multiple cloning site (MCS).
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namethioredoxin-like 4B
-
Alt nameTXNL4B
-
Alt namehuman Dim2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)565
-
Entrez GeneTXNL4B (a.k.a. DLP, Dim2, FLJ20511)
- Promoter T3
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NotI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer T3
- 3′ sequencing primer T7 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
attB cassette flanking coding region of TXNL4B (dim2) can be released by digestion with NotI and BamHI
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBZ-attBtxnl4b was a gift from Yu-Zhu Zhang (Addgene plasmid # 18667 ; http://n2t.net/addgene:18667 ; RRID:Addgene_18667) -
For your References section:
An in vitro recombination method to convert restriction- and ligation-independent expression vectors. Guo F, Chiang MY, Wang Y, Zhang YZ. Biotechnol J. 2008 Mar . 3(3):370-7. 10.1002/biot.200700170 PubMed 18064608